Financial Comparison: Autonomix Medical (AMIX) and Its Rivals

Autonomix Medical (NASDAQ:AMIX) is one of 237 publicly-traded companies in the “Surgical & medical instruments” industry, but how does it compare to its rivals? We will compare Autonomix Medical to related businesses based on the strength of its institutional ownership, analyst recommendations, risk, dividends, profitability, valuation and earnings.

Profitability

This table compares Autonomix Medical and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Autonomix Medical	N/A	-542.11%	-236.92%
Autonomix Medical Competitors	-574.36%	-156.80%	-27.37%

Analyst Recommendations

This is a summary of current recommendations and price targets for Autonomix Medical and its rivals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Autonomix Medical	0	0	1	0	3.00
Autonomix Medical Competitors	1941	4953	9216	273	2.48

Autonomix Medical presently has a consensus price target of $28.00, indicating a potential upside of 777.74%. As a group, “Surgical & medical instruments” companies have a potential upside of 20.10%. Given Autonomix Medical’s stronger consensus rating and higher possible upside, equities analysts clearly believe Autonomix Medical is more favorable than its rivals.

Institutional and Insider Ownership

10.8% of Autonomix Medical shares are owned by institutional investors. Comparatively, 47.7% of shares of all “Surgical & medical instruments” companies are owned by institutional investors. 32.4% of Autonomix Medical shares are owned by insiders. Comparatively, 15.3% of shares of all “Surgical & medical instruments” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Autonomix Medical and its rivals top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Autonomix Medical	N/A	-$15.43 million	-0.20
Autonomix Medical Competitors	$1.01 billion	$10.01 million	-7.25

Autonomix Medical’s rivals have higher revenue and earnings than Autonomix Medical. Autonomix Medical is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Autonomix Medical Company Profile

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.